Tapewire

Nasdaq · USD

IMMX

Immix Biopharma, Inc.

Export transactions ↓
Tapewire entity
4958
SEC CIK
0001873835
Parsed reports
96

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202520
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 22, 2026 Filed May 29, 2026 21:05 UTC GrantStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001493152-26-026426 · ownership.xml · derivative · entry 3

CHANG NANCY T · CIK 0001135041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2036-05-22

F3 · derivative.exercise_date: The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-026426 · ownership.xml · nonDerivative · entry 1

CHANG NANCY T · CIK 0001135041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 428,190

F1 · shares: The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC
Hsu JasonDirector
GrantStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001493152-26-026422 · ownership.xml · derivative · entry 4

Hsu Jason · CIK 0001895035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2036-05-22

F4 · derivative.exercise_date: The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC
Hsu JasonDirector
GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-026422 · ownership.xml · nonDerivative · entry 1

Hsu Jason · CIK 0001895035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 899,250

F1 · shares: The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC
Morris Gabriel SDirector · CFO, President
GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001493152-26-026428 · ownership.xml · derivative · entry 1

Morris Gabriel S · CIK 0001889967 · Director · CFO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2036-05-22

F1 · derivative.exercise_date: The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC GrantStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001493152-26-026429 · ownership.xml · derivative · entry 2

Adams Helen C. · CIK 0001488486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2036-05-22

F2 · derivative.exercise_date: The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-026429 · ownership.xml · nonDerivative · entry 1

Adams Helen C. · CIK 0001488486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,004

F1 · shares: The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC
BUCHAN JANEDirector
GrantStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001493152-26-026423 · ownership.xml · derivative · entry 2

BUCHAN JANE · CIK 0001342502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2036-05-22

F2 · derivative.exercise_date: The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC
BUCHAN JANEDirector
GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-026423 · ownership.xml · nonDerivative · entry 1

BUCHAN JANE · CIK 0001342502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,705

F1 · shares: The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC GrantStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001493152-26-026427 · ownership.xml · derivative · entry 3

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2036-05-22

F3 · derivative.exercise_date: The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-026427 · ownership.xml · nonDerivative · entry 1

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,342

F1 · shares: The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC
Ng CareyDirector
GrantStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001493152-26-026430 · ownership.xml · derivative · entry 3

Ng Carey · CIK 0001889522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2036-05-22

F3 · derivative.exercise_date: The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC
Ng CareyDirector
GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-026430 · ownership.xml · nonDerivative · entry 1

Ng Carey · CIK 0001889522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,250

F1 · shares: The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC
Rachman Ilya MDirector · CEO and Chairman
GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001493152-26-026425 · ownership.xml · derivative · entry 1

Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2036-05-22

F1 · derivative.exercise_date: The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC GrantStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001493152-26-026424 · ownership.xml · derivative · entry 3

Chudnovsky Yekaterina · CIK 0001979324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2036-05-22

F3 · derivative.exercise_date: The stock option will vest in substantially equal monthly installments over the 12 months following the date of grant (or, in the event the 2027 Annual Meeting occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the stock option will vest on the date of such 2027 Annual Meeting), subject to the Reporting Person's continued service on the Issuer's Board through the applicable vesting date.

Read SEC document
May 22, 2026 Filed May 29, 2026 21:05 UTC GrantCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-026424 · ownership.xml · nonDerivative · entry 1

Chudnovsky Yekaterina · CIK 0001979324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,250

F1 · shares: The Reporting Person was granted 6,250 restricted stock units ("RSUs") pursuant to the Issuer's 2021 Equity Incentive Plan, which RSUs will vest in full on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the date that the Issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting") is held, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
December 10, 2025 Filed Dec 10, 2025 23:47 UTC
Morris Gabriel SDirector · CFO
PurchaseCommon Stock 770 $6.58 $5,066.60
Disclosure

SEC source: 0001493152-25-027107 · ownership.xml · nonDerivative · entry 2

Morris Gabriel S · CIK 0001889967 · Director · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,429

Read SEC document
December 10, 2025 Filed Dec 10, 2025 23:49 UTC
Rachman Ilya MDirector · CEO and Chairman
PurchaseCommon Stock 746 $6.67 $4,975.82
Disclosure

SEC source: 0001493152-25-027109 · ownership.xml · nonDerivative · entry 1

Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,141,683

Read SEC document
December 08, 2025 Filed Dec 10, 2025 23:47 UTC
Morris Gabriel SDirector · CFO
OtherWarrants (right to purchase) · Derivative 60,000 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001493152-25-027107 · ownership.xml · derivative · entry 5

Morris Gabriel S · CIK 0001889967 · Director · CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common stock · 60,000 shares

Expires 2031-04-02

F1 · ownership.nature: Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.

F3 · ownership.nature: The warrants were held by Alwaysraise LLC.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 23:47 UTC
Morris Gabriel SDirector · CFO
OtherWarrants (right to purchase) · Derivative 96,000 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001493152-25-027107 · ownership.xml · derivative · entry 4

Morris Gabriel S · CIK 0001889967 · Director · CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common stock · 96,000 shares

Expires 2031-03-18

F1 · ownership.nature: Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.

F3 · ownership.nature: The warrants were held by Alwaysraise LLC.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 23:47 UTC
Morris Gabriel SDirector · CFO
OtherCommon Stock 156,000 $0.80 $124,800.00
Disclosure

SEC source: 0001493152-25-027107 · ownership.xml · nonDerivative · entry 1

Morris Gabriel S · CIK 0001889967 · Director · CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 426,844

F1 · ownership.nature: Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.

Read SEC document
November 21, 2025 Filed Dec 12, 2025 01:00 UTC GrantStock Option (Right to Buy) · Derivative 39,643 $0.00 Strike: $4.33 $0.00
Disclosure

SEC source: 0001493152-25-027329 · ownership.xml · derivative · entry 3

CHANG NANCY T · CIK 0001135041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,643

Underlying: Common Stock · 39,643 shares

Expires 2035-11-21

F2 · derivative.exercise_date: The Stock Option will vest in thirty-six (36) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer and the terms of a Stock Option Agreement entered into to evidence the award.

Read SEC document
September 17, 2025 Filed Sep 17, 2025 21:20 UTC
Rachman Ilya MDirector · CEO and Chairman
PurchaseCommon Stock 2,500 $2.02 $5,050.00
Disclosure

SEC source: 0001493152-25-013919 · ownership.xml · nonDerivative · entry 1

Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,140,937

F1 · price: Volume-weighted average price of purchases which transactions occurred at purchase prices from $2.01 to $2.02 per share, inclusive. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 16, 2025 Filed Sep 17, 2025 21:20 UTC
Morris Gabriel SDirector · CFO
PurchaseCommon Stock 2,600 $1.97 $5,122.00
Disclosure

SEC source: 0001493152-25-013918 · ownership.xml · nonDerivative · entry 1

Morris Gabriel S · CIK 0001889967 · Director · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 290,659

Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:57 UTC
Hsu JasonDirector
GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001641172-25-016112 · ownership.xml · derivative · entry 4

Hsu Jason · CIK 0001895035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2035-06-20

F3 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:57 UTC
Morris Gabriel SDirector · CFO
GrantStock Option (Right to Buy) · Derivative 340,000 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001641172-25-016114 · ownership.xml · derivative · entry 4

Morris Gabriel S · CIK 0001889967 · Director · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 340,000

Underlying: Common Stock · 340,000 shares

Expires 2035-06-20

F3 · derivative.exercise_date: The Stock Option will vest in forty-eight (48) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:57 UTC GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001641172-25-016109 · ownership.xml · derivative · entry 2

Adams Helen C. · CIK 0001488486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2035-06-20

F1 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:57 UTC
BUCHAN JANEDirector
GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001641172-25-016110 · ownership.xml · derivative · entry 2

BUCHAN JANE · CIK 0001342502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2035-06-20

F1 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:57 UTC GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001641172-25-016113 · ownership.xml · derivative · entry 3

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2035-06-20

F1 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:57 UTC
Ng CareyDirector
GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001641172-25-016115 · ownership.xml · derivative · entry 3

Ng Carey · CIK 0001889522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2035-06-20

F2 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:57 UTC
Rachman Ilya MDirector · CEO and Chairman
GrantStock Option (Right to Buy) · Derivative 340,000 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001641172-25-016116 · ownership.xml · derivative · entry 2

Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 340,000

Underlying: Common Stock · 340,000 shares

Expires 2035-06-20

F1 · derivative.exercise_date: The Stock Option will vest in forty-eight (48) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:57 UTC
Chudnovsky YekaterinaDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001641172-25-016111 · ownership.xml · derivative · entry 2

Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2035-06-20

F2 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 13:35 UTC
Morris Gabriel SDirector · CFO
PurchaseCommon Stock 2,225 $2.28 $5,070.78
Disclosure

SEC source: 0001641172-25-015755 · ownership.xml · nonDerivative · entry 1

Morris Gabriel S · CIK 0001889967 · Director · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,059

F1 · price: Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 13:35 UTC
Rachman Ilya MDirector · CEO and Chairman
PurchaseCommon Stock 2,178 $2.30 $4,998.51
Disclosure

SEC source: 0001641172-25-015756 · ownership.xml · nonDerivative · entry 1

Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,138,437

F1 · price: Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 23, 2024 Filed Dec 26, 2024 21:20 UTC
Hsu JasonDirector
PurchaseCommon Stock 40,000 $2.19 $87,680.00
Disclosure

SEC source: 0001493152-24-052103 · ownership.xml · nonDerivative · entry 2

Hsu Jason · CIK 0001895035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 893,000

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.147 to $2.25, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 20, 2024 Filed Dec 26, 2024 21:20 UTC
Hsu JasonDirector
PurchaseCommon Stock 7,700 $2.17 $16,678.20
Disclosure

SEC source: 0001493152-24-052103 · ownership.xml · nonDerivative · entry 1

Hsu Jason · CIK 0001895035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 853,000

F1 · price: This transaction was executed in multiple trades at prices ranging from $2.11 to $2.21, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 22, 2024 Filed Aug 26, 2024 20:45 UTC
Hsu JasonDirector
PurchaseCommon Stock 8,100 $2.25 $18,233.10
Disclosure

SEC source: 0001493152-24-033900 · ownership.xml · nonDerivative · entry 2

Hsu Jason · CIK 0001895035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 845,300

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.162 to $2.29, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 21, 2024 Filed Aug 26, 2024 20:45 UTC
Hsu JasonDirector
PurchaseCommon Stock 15,000 $2.23 $33,390.00
Disclosure

SEC source: 0001493152-24-033900 · ownership.xml · nonDerivative · entry 1

Hsu Jason · CIK 0001895035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 837,200

F1 · price: This transaction was executed in multiple trades at prices ranging from $2.22 to $2.23, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 16, 2024 Filed Aug 20, 2024 00:45 UTC
Ng CareyDirector
PurchaseCommon Stock 10,000 $1.86 $18,600.00
Disclosure

SEC source: 0001493152-24-033205 · ownership.xml · nonDerivative · entry 1

Ng Carey · CIK 0001889522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.84 to $1.915, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 24, 2024 Filed Aug 1, 2024 01:15 UTC
Hsu JasonDirector
PurchaseCommon Stock 6,000 $2.15 $12,877.20
Disclosure

SEC source: 0001493152-24-029810 · ownership.xml · nonDerivative · entry 2

Hsu Jason · CIK 0001895035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 822,200

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.1191 to $2.166, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 18, 2024 Filed Aug 1, 2024 01:15 UTC
Hsu JasonDirector
PurchaseCommon Stock 3,200 $2.07 $6,639.36
Disclosure

SEC source: 0001493152-24-029810 · ownership.xml · nonDerivative · entry 1

Hsu Jason · CIK 0001895035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 816,200

F1 · price: This transaction was executed in multiple trades at prices ranging from $2.06 to $2.07576, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 11, 2024 Filed Jun 21, 2024 21:45 UTC
Hsu JasonDirector
GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.04 $0.00
Disclosure

SEC source: 0001493152-24-024824 · ownership.xml · derivative · entry 4

Hsu Jason · CIK 0001895035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2034-06-11

F3 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
June 11, 2024 Filed Jun 21, 2024 21:45 UTC
Morris Gabriel SDirector · CFO
GrantStock Option (Right to Buy) · Derivative 340,000 $0.00 Strike: $2.04 $0.00
Disclosure

SEC source: 0001493152-24-024826 · ownership.xml · derivative · entry 4

Morris Gabriel S · CIK 0001889967 · Director · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 340,000

Underlying: Common Stock · 340,000 shares

Expires 2034-06-11

F3 · derivative.exercise_date: The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 11, 2024 Filed Jun 21, 2024 21:45 UTC GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.04 $0.00
Disclosure

SEC source: 0001493152-24-024821 · ownership.xml · derivative · entry 2

Adams Helen C. · CIK 0001488486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2034-06-11

F1 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
June 11, 2024 Filed Jun 21, 2024 21:45 UTC
BUCHAN JANEDirector
GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.04 $0.00
Disclosure

SEC source: 0001493152-24-024822 · ownership.xml · derivative · entry 2

BUCHAN JANE · CIK 0001342502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2034-06-11

F1 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 11, 2024 Filed Jun 21, 2024 21:45 UTC GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.04 $0.00
Disclosure

SEC source: 0001493152-24-024825 · ownership.xml · derivative · entry 3

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2034-06-11

F1 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 11, 2024 Filed Jun 21, 2024 21:45 UTC
Chudnovsky YekaterinaDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.04 $0.00
Disclosure

SEC source: 0001493152-24-024823 · ownership.xml · derivative · entry 2

Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2034-06-11

F2 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
June 11, 2024 Filed Jun 21, 2024 21:45 UTC
Rachman Ilya MDirector · CEO and Chairman
GrantStock Option (Right to Buy) · Derivative 340,000 $0.00 Strike: $2.04 $0.00
Disclosure

SEC source: 0001493152-24-024828 · ownership.xml · derivative · entry 2

Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 340,000

Underlying: Common Stock · 340,000 shares

Expires 2034-06-11

F1 · derivative.exercise_date: The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 11, 2024 Filed Jun 21, 2024 21:45 UTC
Ng CareyDirector
GrantStock Option (Right to Buy) · Derivative 33,000 $0.00 Strike: $2.04 $0.00
Disclosure

SEC source: 0001493152-24-024827 · ownership.xml · derivative · entry 3

Ng Carey · CIK 0001889522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,000 shares

Expires 2034-06-11

F2 · derivative.exercise_date: The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.

Read SEC document
June 07, 2024 Filed Jun 10, 2024 13:00 UTC
Morris Gabriel SDirector · CFO
PurchaseCommon Stock 2,500 $2.12 $5,298.00
Disclosure

SEC source: 0001493152-24-023288 · ownership.xml · nonDerivative · entry 1

Morris Gabriel S · CIK 0001889967 · Director · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,834

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.